Economic TimesLean R·
Govt eases BA-BE study norms
New Delhi: The government will soon make it easier for pharmaceutical companies to conduct bioavailability and bioequivalence (BA-BE) studies for domestic drug approvals, allowing applicants to start eligible trials after intimating the drug regulator instead of seeking its prior permission, people familiar with the matter told ET.BA-BE studies are critical components of the process to approve generic drugs. They are used to prove that the generic version acts exactly the same way in the body a…
Read at Economic Times →
